Cognitive Impairment Clinical Trials in Belmont, Massachusetts
5 recruitingBelmont, Massachusetts
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
Mild Cognitive ImpairmentMild Alzheimer Disease
Mclean Hospital50 enrolled1 locationNCT04430517
Recruiting
Phase 2
Study of ALTO-101 in Patients With Schizophrenia
Cognitive ImpairmentSchizophrenia
Alto Neuroscience82 enrolled14 locationsNCT06502964
Recruiting
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting
Phase 2Phase 3
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Cognitive ImpairmentMitochondrial AlterationSchizophrenia and Related Disorders
Mclean Hospital100 enrolled3 locationsNCT06191965
Recruiting
Early Phase 1
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
AnxietyAlzheimer DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease+1 more
Mclean Hospital12 enrolled1 locationNCT04075435